VF
CRBP icon

Virtu Financial’s Corbus Pharmaceuticals CRBP Stock Holding History

Virtu Financial’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,760
Closed -$88K – 1731
2025
Q4 		$88K Buy
+10,760
New +$133K ﹤0.01% 1227
2023
Q2 		– Sell
-10,077
Closed -$73K – 1599
2023
Q1 		$73K Buy
+10,077
New +$44.1K 0.01% 1038
2022
Q2 		– Sell
-1,014
Closed -$16K – 1652
2022
Q1 		$16K Buy
+1,014
New +$13.4K ﹤0.01% 1321
2021
Q4 		– Sell
-5,346
Closed -$164K – 1783
2021
Q3 		$164K Buy
5,346
+2,512
+89% +$99.1K 0.01% 975
2021
Q2 		$156K Sell
2,834
-2,257
-44% -$125K 0.02% 1078
2021
Q1 		$301K Sell
5,091
-39
-0.8% -$2.56K 0.02% 815
2020
Q4 		$192K Buy
+5,130
New +$192K 0.02% 876
2020
Q3 		– Sell
-952
Closed -$240K – 1137
2020
Q2 		$240K Buy
+952
New +$192K 0.03% 643
2019
Q4 		$97K Buy
+594
New +$87.8K 0.01% 1091
2019
Q3 		– Sell
-955
Closed -$199K – 1475
2019
Q2 		$199K Buy
+955
New +$204K 0.01% 1027
2019
Q1 		– Sell
-427
Closed -$75K – 1466
2018
Q4 		$75K Buy
427
+1
+0.2% +$200 ﹤0.01% 1202
2018
Q3 		$96K Sell
426
-229
-35% -$37K 0.01% 1197
2018
Q2 		$99K Buy
655
+171
+35% +$31.1K 0.01% 1649
2018
Q1 		$89K Buy
+484
New +$109K ﹤0.01% 1601

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial's CRBP Position: Q1 2026 in Review

Virtu Financial sold out of Corbus Pharmaceuticals (CRBP) in Q1 2026, closing a stake of 10,760 shares — an estimated $88K sold.

Virtu Financial first reported a position in CRBP in Q1 2018 and held it in 14 quarters. The position peaked at $301K in Q1 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Virtu Financial reported no remaining Corbus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,760 Corbus Pharmaceuticals shares in Q1 2026, an estimated $88K.
  • Virtu Financial first reported a position in Corbus Pharmaceuticals in Q1 2018 and held it in 14 quarters.
  • Virtu Financial's Corbus Pharmaceuticals position peaked at $301K in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.